- Home
- ALNY vs ODFL Comparison
ALNY vs ODFL Comparison
Compare ALNY & ODFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- ODFL
- Stock Information
- Founded
- ALNY 2002
- ODFL 1934
- Country
- ALNY United States
- ODFL United States
- Employees
- ALNY N/A
- ODFL N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- ODFL Trucking Freight/Courier Services
- Sector
- ALNY Health Care
- ODFL Industrials
- Exchange
- ALNY Nasdaq
- ODFL Nasdaq
- Market Cap
- ALNY 39.6B
- ODFL 34.3B
- IPO Year
- ALNY 2004
- ODFL 1991
- Fundamental
- Price
- ALNY $309.70
- ODFL $156.46
- Analyst Decision
- ALNY Strong Buy
- ODFL Buy
- Analyst Count
- ALNY 25
- ODFL 21
- Target Price
- ALNY $324.96
- ODFL $176.33
- AVG Volume (30 Days)
- ALNY 849.2K
- ODFL 1.5M
- Earning Date
- ALNY 07-31-2025
- ODFL 07-23-2025
- Dividend Yield
- ALNY N/A
- ODFL 0.72%
- EPS Growth
- ALNY N/A
- ODFL N/A
- EPS
- ALNY N/A
- ODFL 5.33
- Revenue
- ALNY $2,348,099,000.00
- ODFL $5,729,595,000.00
- Revenue This Year
- ALNY $30.77
- ODFL N/A
- Revenue Next Year
- ALNY $30.51
- ODFL $8.27
- P/E Ratio
- ALNY N/A
- ODFL $29.27
- Revenue Growth
- ALNY 17.21
- ODFL N/A
- 52 Week Low
- ALNY $153.23
- ODFL $144.90
- 52 Week High
- ALNY $317.54
- ODFL $233.26
- Technical
- Relative Strength Index (RSI)
- ALNY 63.60
- ODFL 42.47
- Support Level
- ALNY $295.82
- ODFL $159.42
- Resistance Level
- ALNY $317.54
- ODFL $170.26
- Average True Range (ATR)
- ALNY 7.74
- ODFL 4.23
- MACD
- ALNY -0.67
- ODFL -0.85
- Stochastic Oscillator
- ALNY 63.90
- ODFL 6.19
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About ODFL Old Dominion Freight Line Inc.
Old Dominion Freight Line is the second-largest less-than-truckload carrier in the United States (following FedEx Freight), with more than 250 service centers and 11,000-plus tractors. It is one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns are head and shoulders above its peers. Strategic initiatives revolve around boosting network density through market share gains and maintaining industry-leading service (including ultralow cargo claims) via steadfast infrastructure investment.